Skip to content

CEGEPHAR

Active
Private limited companyfounded 1993active for 33 yearsRue Emile Vandervelde 30, 4624 Fléron, BelgiumKBO/BCE: BE 0450.412.570

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
10-07
NBB filing Annual accounts 2025 filedNBB
abbreviated format · 21 days before the deadline
2025
31-12
Financial Highest result from 2018 to 2025net €108,204 ▲26%
The operating result of €141,049 and the net result of €108,204 are both a record.
31-12
Financial Equity above €200,000equity €200,669 ▲31.6%
After 5 profitable years in a row, equity reaches €200,669.
19-06
NBB filing Annual accounts 2024 filedPDF
full format · 42 days before the deadline
2024
31-12
Financial Equity above €150,000equity €152,465 ▲20.4%
After 4 profitable years in a row, equity reaches €152,465.
14-06
NBB filing Annual accounts 2023 filedPDF
full format · 47 days before the deadline
2023
31-12
Financial Equity above €100,000equity €126,601 ▲45.5%
After 3 profitable years in a row, equity reaches €126,601.
26-07
NBB filing Annual accounts 2022 filedPDF
full format · 5 days before the deadline
2022
22-09
Gazette deed Reappointment: PHARMACIE FONZE (director)
Permanent representative: FONZE Denis · Amendment of the articles · Capital conversion10 points ▸
  • General meeting, 13-09-2022
  • Amendment of the articles, mentioned 2 times in the deed
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Other provision, “absence de compte apports non appelés, totalité du capital libérée” (deed in French)
  • Reserve release, “unanimité, suppression du compte de capitaux propres statutairement indisponible” (deed in French)
  • Share issue, 1300, “Article cinq” (deed in French)
  • Director reappointment, PHARMACIE FONZE (director (not named in the articles))
  • Permanent representative, FONZE Denis
  • Registered office clause, “unanimité, 4624 Romsée (Fléron), rue Emile Vandervelde 30” (deed in French)
  • Power of attorney

Open the act in the Belgian Official Gazette

02-06
NBB filing Annual accounts 2021 filedPDF
full format · 59 days before the deadline
2021
31-12
Financial Back to profitnet €74,825
The net result is €74,825, after one loss-making year.
16-07
NBB filing Annual accounts 2020 filedPDF
full format · 15 days before the deadline
Show earlier events
2020
31-12
Financial Weakest financial yearnet -€12,369
The net result drops to -€12,369, the lowest from 2018 to 2025. It recovers the following year.
10-08
NBB filing Annual accounts 2019 filedPDF
full format · 10 days late
2019
29-04
NBB filing Annual accounts 2018 filedPDF
full format · 93 days before the deadline
2018
23-05
NBB filing Annual accounts 2017 filedPDF
full format · 69 days before the deadline
2017
26-04
NBB filing Annual accounts 2016 filedPDF
full format · 96 days before the deadline
1993
20-07
Gazette deed Incorporation
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 16 June 1993, CEGEPHAR was incorporated.1 PHARMACIE FONZE is director of the company according to the act of 22-09-2022.2 Total assets went from €869,287 in 2018 to €787,032 in 2025 and headcount from 4 to 4.4 full-time equivalents.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 22-09-2022
  3. 3National Bank, annual accounts 2018 and 2025

Next steps